Zephyrm Biotech Overview
- Year Founded
-
2018
- Status
-
IPO Registration
- Employees
-
97
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
14
Zephyrm Biotech General Information
Description
Developer and producer of stem cell drugs focusing on PSC-derived cell therapy. The company develops stem cell drugs with independent intellectual property rights, and promotes the clinical application and industrial transformation of stem cells, enabling clients to meet the needs that cannot be satisfied by current traditional medicines and treatment methods.
Contact Information
Website
www.zephyrm.comCorporate Office
- Floor 6, Block A, Pangu Daguan Office Building
- No. 27 North Fourth Ring Middle Road, Chaoyang District
- Beijing
- China
Corporate Office
- Floor 6, Block A, Pangu Daguan Office Building
- No. 27 North Fourth Ring Middle Road, Chaoyang District
- Beijing
- China
Zephyrm Biotech Timeline
Zephyrm Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. IPO | 01-Oct-2024 | Announced | Clinical Trials - General | |||
| 6. Secondary Transaction - Private | 22-Mar-2024 | Completed | Clinical Trials - General | |||
| 5. Early Stage VC (Series B2) | 25-Apr-2024 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC (Series B1) | 27-Dec-2023 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series B) | 12-Dec-2022 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 14-Apr-2021 | $24.4M | $45.8M | Completed | Clinical Trials - General | |
| 1. Early Stage VC | 27-Dec-2019 | $21.4M | $21.4M | Completed | Clinical Trials - General |
Zephyrm Biotech Signals
Zephyrm Biotech Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Huairou Science City Technology Services | Corporation | Minority | ||
| Guangdong Technology Financial Group | Government | Minority | ||
| Zhongshan Financial Investment | Venture Capital | Minority | ||
| Zhongshan Health Base Group | Government | Minority | ||
| Zhongshan Torch Electronic Industry Fund Management | Venture Capital | Minority |
Zephyrm Biotech FAQs
-
When was Zephyrm Biotech founded?
Zephyrm Biotech was founded in 2018.
-
Where is Zephyrm Biotech headquartered?
Zephyrm Biotech is headquartered in Beijing, China.
-
What is the size of Zephyrm Biotech?
Zephyrm Biotech has 97 total employees.
-
What industry is Zephyrm Biotech in?
Zephyrm Biotech’s primary industry is Drug Discovery.
-
Is Zephyrm Biotech a private or public company?
Zephyrm Biotech is a Private company.
-
What is Zephyrm Biotech’s current revenue?
The current revenue for Zephyrm Biotech is .
-
How much funding has Zephyrm Biotech raised over time?
Zephyrm Biotech has raised $89.1M.
-
Who are Zephyrm Biotech’s investors?
Beijing Huairou Science City Technology Services, Guangdong Technology Financial Group, Zhongshan Financial Investment, Zhongshan Health Base Group, and Zhongshan Torch Electronic Industry Fund Management are 5 of 14 investors who have invested in Zephyrm Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process